Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

271
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
271

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Developing a Screening Strategy to Identify Hepatotoxicity and Drug Interaction Potential of Botanicals.

Journal of dietary supplements·2024
Same author

Advances in Animal Models and Cutting-Edge Research in Alternatives: Proceedings of the Third International Conference on 3Rs Research and Progress, Vishakhapatnam, 2022.

Alternatives to laboratory animals : ATLA·2023
Same author

Permeabilized Cryopreserved Human Hepatocytes as an Exogenous Metabolic System in a Novel Metabolism-Dependent Cytotoxicity Assay for the Evaluation of Metabolic Activation and Detoxification of Drugs Associated with Drug-Induced Liver Injuries: Results with Acetaminophen, Amiodarone, Cyclophosphamide, Ketoconazole, Nefazodone, and Troglitazone.

Drug metabolism and disposition: the biological fate of chemicals·2021
Same author

Messenger RNA Expression of Albumin, Transferrin, Transthyretin, Asialoglycoprotein Receptor, Cytochrome P450 Isoform, Uptake Transporter, and Efflux Transporter Genes as a Function of Culture Duration in Prolonged Cultured Cryopreserved Human Hepatocytes as Collagen-Matrigel Sandwich Cultures: Evidence for Redifferentiation upon Prolonged Culturing.

Drug metabolism and disposition: the biological fate of chemicals·2021
Same author

3D cell culture models: Drug pharmacokinetics, safety assessment, and regulatory consideration.

Clinical and translational science·2021
Same author

Prolonged cultured human hepatocytes as an in vitro experimental system for the evaluation of potency and duration of activity of RNA therapeutics: Demonstration of prolonged duration of gene silencing effects of a GalNAc-conjugated human hypoxanthine phosphoribosyl transferase (HPRT1) siRNA.

Biochemical pharmacology·2020

Related Experiment Video

Updated: May 3, 2026

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection
10:25

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection

Published on: February 19, 2019

13.1K

Biomarkers and human hepatocytes.

Albert P Li1

  • 1In Vitro ADMET Laboratories LLC, 9221 Rumsey Road Suite 8, Columbia, MD 21045, USA. lialbert@invitroadmet.com.

Biomarkers in Medicine
|February 14, 2014
PubMed
Summary

Human hepatocytes offer a reliable in vitro method to predict drug toxicity and interactions, improving preclinical safety evaluations. This approach avoids harm to patients and provides crucial human-specific drug metabolism data.

Area of Science:

  • Pharmacology
  • Toxicology
  • Drug Metabolism

Background:

  • Preclinical safety evaluations often fail to predict human toxicity due to species differences in drug metabolism and toxic mechanisms.
  • In vitro human-based systems offer a practical solution for assessing human-specific drug properties, saving time, resources, and avoiding patient harm.

Purpose of the Study:

  • To review the application of human hepatocytes in evaluating drug-drug interactions and hepatotoxicity.
  • To highlight the utility of human hepatocytes as a model for human-specific drug metabolism and toxicity assessment.

Main Methods:

  • Utilizing human hepatocytes to assess metabolism-based drug-drug interactions, including metabolite profiling, pathway identification, CYP450 inhibition/induction, and transporter inhibition.
  • Employing human hepatocytes for in vitro hepatotoxicity and metabolism-based drug toxicity evaluations.

More Related Videos

Human Liver Spheroids from Peripheral Blood for Liver Disease Studies
09:51

Human Liver Spheroids from Peripheral Blood for Liver Disease Studies

Published on: January 27, 2023

2.1K
Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
11:06

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro

Published on: January 31, 2022

7.6K

Related Experiment Videos

Last Updated: May 3, 2026

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection
10:25

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection

Published on: February 19, 2019

13.1K
Human Liver Spheroids from Peripheral Blood for Liver Disease Studies
09:51

Human Liver Spheroids from Peripheral Blood for Liver Disease Studies

Published on: January 27, 2023

2.1K
Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
11:06

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro

Published on: January 31, 2022

7.6K
  • Exploring the correlation of drug toxicity with proteomics and genomics data for biomarker discovery.

    • Main Results:

    • Human hepatocytes provide a comprehensive system for evaluating drug metabolism due to complete hepatic enzymes, transporters, and cofactors.
    • The use of human hepatocytes is effective for assessing drug-drug interactions and hepatotoxicity.
    • Integration with proteomics and genomics may lead to early detection biomarkers for liver toxicity.

    Conclusions:

    • Human hepatocytes are a valuable tool for in vitro preclinical drug safety assessment, offering human-specific insights.
    • This in vitro approach enhances the prediction of drug-induced liver injury and drug-drug interactions.
    • Future research integrating omics data with hepatocyte studies can improve early detection of clinical liver toxicity.